Refers to the development of detectable antibodies in the blood that are specific to a given organism such as a virus. Most often used in reference to HIV-negative to HIV-positive conversion, but may also be used in reference to hepatitis B or other pathogens.
The contents of this glossary is funded in part through a sub-award from RTI as the lead partner for the National Institute of Justice’s Forensic Technology Center of Excellence through a Cooperative Agreement from the National Institute of Justice (2011-DN-BX-K564 and 2016-MU-BK-K110), Office of Justice Programs, U.S. Department of Justice. Neither the U.S. Department of Justice nor any of its components operate, control, are responsible for, or necessarily endorse, this website (including, without limitation, its content, technical infrastructure, and policies and any services or tools provided).